BC3H-1 myocytes were cultured in the presence of [3H]inositol or [3H]glucosamine during their entire growth cycle to ensure that all lipids containing inositol and glucosamine were labelled to isotopic equilibrium or maximal specific radioactivity. After such labelling, a lipid (or group of lipids), which was labelled with both inositol and glucosamine, was observed to migrate between phosphatidylinositol 4-phosphate and phosphatidylinositol (PI) in two different t.l.c. systems. Insulin provoked rapid, sizeable, increases in the inositol-labelling of this lipid (presumably a PI-glycan), and these increases were similar to those observed in PI and PI phosphates. Our results indicate that insulin provokes co-ordinated increases in the net synthesis de novo of PI and its derivatives, PI phosphates and the PI-glycan, in BC3H-1 myocytes. This increase in synthesis of PI may serve as the mechanism for replenishing the PI-glycan during stimulation of its hydrolysis by insulin. Moreover, increases in the content of the PI-glycan may contribute to increases in the generation of head-group 'mediators' during insulin action.
INTRODUCTION
Insulin is known to increase the net synthesis of phosphatidylinositol (PI) and its mono-and bisphosphates (PIP and PIP2) in BC3H-1 myocytes [1, 2] and rat adipocytes [2] [3] [4] . Saltiel et al. [5] have reported that insulin activates a phospholipase C which hydrolyses a PI-glucosamine complex (PI-glycan) in BC3H-1 myocytes, and the head group of this, or other related glycolipids, is thought to account for certain actions of insulin in several tissues [5] [6] [7] [8] [9] . In [3H]inositol-and [3H]glucosamine-labelling experiments in BC3H-1 myocytes, Saltiel et al. [5] have also observed that the hydrolysis of the PI-glycan is accompanied by increases in labelling by both precursors. However, in these relatively short-term labelling experiments, it was unclear whether the increase in [3H] [1, 2] ). In some experiments, the lipid extracts were chromatographed (system B) on silica-gel plates impregnated with 1 potassium oxalate, developed with chloroform/acetone/methanol/acetic acid/water (5:2:2: 1: 1, by vol.) (see [5] ). In some experiments, the acid-soluble fractions were analysed for [3H]inositol labelling of total inositol phosphates (monoplus poly-phosphates) as described previously [2] . and, in the experiment portrayed in Fig. 3 
DISCUSSION
In accordance with the reports by Saltiel et al. [5] [6] [7] , we found that BC3H-1 myocytes contain a lipid (or group of lipids), which migrates between PIP and PI in two different t.l.c. systems, and appears to contain both glucosamine and inositol. Furthermore,,insulin treatment provoked changes (i.e. variable initial decreases, followed by increases) in this lipid, and, in accordance with evidence presented by Saltiel et al. [5] [6] [7] , this lipid appears to be the insulin-sensitive PI-glycan.
Under the present experimental conditions, there was little question that inositol-containing lipids were labelled with [3H]inositol to isotopic equilibrium (or to a specific radioactivity that would be maximal at the beginning of the experimental treatment period), as the cells were exposed to labelled inositol during their entire growth cycle. Thus it may be estimated that, in the BC3H-1 myocyte, the mass of the PI-glycan is approx. 50 of that of PI, and this is similar to that of PIP and PIP2, which combined are equal to 100 of PI.
As it is likely that inositol lipids were labelled to isotopic equilibrium or maximal specific radioactivity, the insulin-induced increases in PI, PIP, PIP2 and the PIglycan can be taken as strong evidence that insulin increases the net synthesis and mass of these substances. (It is possible that [3H]inositol could be diluted from metabolism of glucose to inositol, but this metabolism would be expected to be increased by insulin and would therefore only result in an underestimation of the insulin effect.) Moreover, the fact that all of these inositolcontaining lipids changed in parallel suggests that these effects of insulin are co-ordinated. The simplest explanation for these co-ordinated increases is that insulin increases net synthesis de novo of PI, which then serves as substrate for subsequent synthesis of its derivatives, i.e. PIP, PIP2 and the PI-glycan.
It may be noted that, although initial transient insulininduced decreases in the PI-glycan were comparable in inositol-and glucosamine-labelled cells (see Table 1 ), subsequent increases in [3H]glucosamine labelling of the PI-glycan were substantially less than increases in
[3H]inositol labelling of this lipid (cf. Figs. 1 and 3 ). This was regularly observed and probably reflects that there may be relatively little inositol synthesis or metabolic losses in the myocyte culture system (save for incorporation into inositol lipids and their inositol phosphate derivatives), whereas glucosamine is undoubtedly continually being synthesized from glucose over the 10-day labelling period. (Note that the culture medium contains inositol and glucose, but not glucosamine). Thus the specific radioactivity of glucosamine may have decreased much more than that of inositol over the 10-day culture period, and during subsequent insulin treatment the newly synthesized PI-glycan may be labelled with glucosamine of much lower specific radioactivity than that synthesized much earlier, particularly during the exponential growth phase, which occurs soon after subculturing. For these reasons, [3H]inositol would be expected to be a better indicator of net synthesis of the PI-glycan than [3H]glucosamine during insulin stimulation. Nevertheless, even though [3H]glucosamine labelling may underestimate the real insulin-induced increases in the PI-glycan, increases (after initial decreases) were regularly observed, and this clearly reflects net synthesis rather than simple turnover.
It is uncertain whether insulin-induced increases in the content of some of the inositol lipids may be due to decreased hydrolytic turnover, rather than increased synthesis. Along these lines, despite remarkable increases in the mass of all inositol lipids in the experiment of Fig.  3 , inositol phosphates did not change appreciably, and this suggests that there is a decreased fractional rate of turnover, but an unchanged total turnover, of inositol lipids through this pathway. Although we did not measure the release of PI-glycan head groups, Saltiel et al. [5] have documented that this is stimulated by insulin in BC3H-1 myocytes, probably through stimulated hydrolysis of the PI-glycan by a relatively specific phospholipase C, which does not hydrolyse PI directly. Thus, although phospholipase C-mediated hydrolysis of PIP2, PIP and PI does not appear to be increased by insulin, conversion of PI into the PI-glycan is apparently stimulated, and this argues against the possibility that increases in PI content are due to decreased hydrolytic turnover. It is possible, however, that hydrolytic turnover of PIP and PIP2 may be diminished during insulin treatment.
As reported previously [10] the increase in PI synthesis de novo which is observed between 2 and 20 min of insulin treatment in BC3H-1 myocytes appears to occur largely at the expense of pre-existing phospholipids, rather than from phosphatidic acid (PA) synthesized de novo from glycerol 3-phosphate and fatty acyl-CoA. Phospholipids, such as phosphatidylcholine and phosphatidylethanolamine, may be converted into PI through diacylglycerol and PA, by a stimulation of either phospholipase C or phospholipase D. In either case, the increase in PA would lead to an increase in CDPdiacylglycerol, and ultimately to PI and its derivatives.
It is of interest that net synthesis of PI, PIP and PIP2 has been observed, not only with insulin treatment in several tissues [1] [2] [3] 10] , but also with corticotropin and angiotensin II treatment in adrenal tissue [11, 12] . A Plglycan has now been found in adrenal tissue [13] , and this raises the possibility that a number of hormones may use synthesis of PI de novo as the back-up mechanism to resynthesize the PI-glycan during hormone-induced hydrolysis of the latter by a specific phospholipase C. Moreover, increases in the synthesis of the PI-glycan through these mechanisms could serve to amplify the hydrolysis response and increase the generation of head-group 'mediators' for insulin and perhaps other hormones.
In summary, our findings suggest that the mechanism for replenishing the PI-glycan, after its hydrolysis during insulin treatment in BC3H-1 myocytes, is through synthesis of PI de novo (from PA derived both from hydrolysis of pre-existing non-inositol phospholipids and from PA synthesis de novo from glycerol 3-phosphate and fatty acyl-CoA), and subsequent rapid conversion of this PI into the PI-glycan. Resultant increases in the synthesis of the PI-glycan could enhance the production of head-group 'mediators' and contribute importantly to mediator-dependent biological effects of insulin.
